~~<i id='B9E925C343'><strike id='B9E925C343'><tt id='B9E925C343'><pre id='B9E925C343'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-09-28 04:13:13 Page View：38539

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： CRISPR base editing slashes cholesterol levels in monkeys
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

European officials brace for rough respiratory virus season

FinnbarrWebster/GettyImagesLONDON—HealthofficialsintheU.K.andEuropearerampinguptheircampaignsurginge

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Study points to new risk in gene therapy death of Terry Horgan

TerryHorganinhisfamily'sMontourFalls,N.Y.,home,inanundatedphoto.KateCollins/TheJournalviaAPLastOctob